Home / Journals American Journal of Clinical and Experimental Medicine / Clinical Innovations, Developments in the Diagnosis, Management and Prevention of Ebola Disease (Marburg fever) and Hemorrhagic Fevers
Clinical Innovations, Developments in the Diagnosis, Management and Prevention of Ebola Disease (Marburg fever) and Hemorrhagic Fevers
Submission Deadline: Dec. 30, 2014

This special issue currently is open for paper submission and guest editor application.

Join as Guest Editor Submit to Special Issue
Lead Guest Editor
Kenneth Anchang Yongabi
NMD School Of Health and Medical Science, Phytobiotechnology Research Institute, Catholic University of Cameroon, Bamenda, Cameroon
Guest Editor
Guest Editors play a significant role in a special issue. They maintain the quality of published research and enhance the special issue’s impact. If you would like to be a Guest Editor or recommend a colleague as a Guest Editor of this special issue, please Click here to fulfill the Guest Editor application.
Guidelines for Submission
Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.
Papers should be formatted according to the guidelines for authors (see: http://www.sciencepublishinggroup.com/journal/guideforauthors?journalid=254). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.
Published Papers
1
Authors: Kenneth Yongabi Anchang, Mary Garba, Florence Titu Manjong, Tiagueu Yvette T
Pages: 1-6 Published Online: Feb. 14, 2015
DOI:
Views 4296 Downloads 152
2
Authors: Kenneth Anchang Yongabi
Pages: 7-13 Published Online: Feb. 15, 2015
DOI:
Views 3233 Downloads 128
3
Authors: Mary Bi Suh Atanga, Ndipowa James Attangeur, Kenneth Yongabi Anchang
Pages: 14-20 Published Online: Feb. 15, 2015
DOI:
Views 3011 Downloads 226
4
Authors: Ndipowa a James Attangeur Chimfutumb, Mary Bih Suh Atanga, Elvis Fon Tata, Kenneth Yongabi Anchang
Pages: 21-23 Published Online: Feb. 15, 2015
DOI:
Views 3029 Downloads 137
5
Authors: Kenneth Anchang Yongabi, Laura. DeLuca, Keto Mshigeni, Suki K. K. Mwendwa, Alex Dudley, Francisca Nambu Njuakom
Pages: 24-28 Published Online: Feb. 15, 2015
DOI:
Views 3112 Downloads 137
6
Authors: Polycarp Chia, Elvis Fon Tatah, Kenneth Yongabi
Pages: 29-32 Published Online: Feb. 15, 2015
DOI:
Views 2782 Downloads 107
7
Authors: Kenneth Anchang Yongabi , Florence Titu Manjong , Mary Chia Garba , Daniel Martinez-Carrera
Pages: 33-37 Published Online: Feb. 27, 2015
DOI:
Views 3049 Downloads 88
8
Authors: Kenneth Anchang Yongabi, Judith Abit Nota, Gilbert Nota Teko
Pages: 38-45 Published Online: Feb. 28, 2015
DOI:
Views 2687 Downloads 89
Introduction
Effective intervention strategy to contain Ebola disease and epidemic remains daunting. Ebola which is ranks as one of the deadliest contemporary scourge has killed more than 5000 people in just a couple of months. Ebola Virus Disease (EVD) formerly known as Ebola hemorrhagic fever closely resembles Marburg hemorrhagic fever in its clinical manifestations is a severe, often fatal illness in humans. EVD has a fatality rate of above 90%. Ebola is introduced into the human population through close contact with the blood, secretions, organs or other bodily fluids of infected animals. In Africa, infection has been documented through the handling of infected chimpanzees, gorillas, fruit bats, monkeys, forest antelope and porcupines found ill or dead or in the rain forest. Ebola then spreads in the community through human-to-human transmission, with infection resulting from direct contact (through broken skin or mucous membranes) with the blood, secretions, organs or other bodily fluids of infected people, and indirect contact with environments contaminated with such fluids. Burial ceremonies in which mourners have direct contact with the body of the deceased person can also play a role in the transmission of Ebola. Men who have recovered from the disease can still transmit the virus through their semen for up to 7 weeks after recovery from illness. Health-care workers have frequently been infected while treating patients with suspected or confirmed EVD. This has occurred through close contact with patients when infection control precautions are not strictly practiced. Among workers in contact with monkeys or pigs infected with Reston ebolavirus, several infections have been documented in people who were clinically asymptomatic. The current global approach to the tackle Ebola still inadequate to contain this scourge. There are, ultimately, a lot of clinical, scientific and epidemiological and social gaps required to be able to effectively address the global ebola threats. For this purpose, Kenneth Yongabi of the Catholic University of Cameroon organized and convened a conference in September 2014 that looked at several scientific, clinical, and anthropological and possibly control strategies for EVD in Africa.The articles discussed during that session are being published in this special edition of this journal. The aim of this special edition is to provide an opportunity for all medical, health care personnel, the entire global scientific community to publish scientific updates on EVD. It would also provide an opportunity for scientists to share and to network and share new ideas on how to prevent, manage and contain the EVD.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186